Discriminating subjects at clinical high risk (CHR) for psychosis who will develop psychosis
from those who will not is a prerequisite for preventive treatments. However, it is not yet …

A large array of studies have investigated peripheral oxytocin (OT) and vasopressin (ADH)
as potential biomarkers of psychiatric disorders, with highly conflicting and heterogenous …

Importance Individuals can be classified as being at clinical high risk (CHR) for psychosis if
they meet at least one of the ultra–high-risk (UHR) inclusion criteria (brief limited intermittent …

An accurate detection of individuals at clinical high risk (CHR) for psychosis is a prerequisite
for effective preventive interventions. Several psychometric interviews are available, but …

Background: The individual risk of developing psychosis after being tested for clinical high-risk
(CHR) criteria (posttest risk of psychosis) depends on the underlying risk of the disease of …

Background: Validity of current International Classification of Disease/Diagnostic and Statistical
Manual of Mental Disorders (ICD/DSM) first episode psychosis diagnoses is essential in …

Importance The prognostic significance of competing constructs and operationalizations for
brief psychotic episodes (acute and transient psychotic disorder [ATPD], brief psychotic …

Background Patients at ultra-high risk for psychosis (UHR) are a highly heterogeneous group
in terms of clinical and functional outcomes. Several non-psychotic mental disorders co-…

Background Brief Limited Intermittent Psychotic Symptoms (BLIPS) are key inclusion criteria
to define individuals at ultra high risk for psychosis (UHR). Their diagnostic and prognostic …

Background. Several psychometric instruments are available for the diagnostic interview of
subjects at ultra high risk (UHR) of psychosis. Their diagnostic comparability is unknown. …